Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma

被引:34
作者
Zhang, Megan Q.
Lin, Fan
Hui, Pei
Chen, Zong-Ming E.
Ritter, Jon H.
Wang, Hanlin L.
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, Lauren V Ackerman Lab Surg Pathol, St Louis, MO USA
[2] Geisinger Med Ctr, Dept Lab Med, Danville, PA 17822 USA
[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
small intestine; colorectal; adenocarcinoma; mucin; small-intestinal mucin antigen; villin; CDX2;
D O I
10.1309/JAF3KVGJHQCJ1QF9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Expression of gastrointestinal biomarkers MUCI, MUC2, MUC5AC, small-intestinal mucin antigen (SIMA), villin, and CDX2 has been studied in colorectal adenocarcinoma (CRC). Little is known, however, about their expression in small-intestinal adenocarcinoma (SIA). We immunohistochemically compared 30 SIAs with 48 CRCs for the expression of these biomarkers. The results showed that all 6 proteins were variably expressed in SIA, but the frequencies of expression were significantly lower than those for CRC with the exception of MUC1 Specifically, positive staining for MUCI, MUC2, MUC5AC, SIMA villin, and CDX2 was observed in 16 (53%), 17 (57%), 12 (40%), 15 (50%), 20 (67%), and 18 (60%) of SlAs and 25 (52%), 43 (90%), 39 (81%), 45 (94%), 47 (98%), and 47 (98%) of CRCs, respectively. In addition, SIAs morefrequently exhibited afocal staining pattern for MUC2, MUC5AC, SIMA, and villin, whereas more diffuse immunoreactivity was evident in CRCs. Focal staining for MUCI and diffuse staining for CDX2 were common for SIAs and CRCs. Furthermore, poorly differentiated SIAs tended to express MUCI more frequently when compared with well- and moderately differentiated SIAs. These observations further support the notion that SIA is immunophenotypically distinct from CRC despite their morphologic similarity.
引用
收藏
页码:808 / 816
页数:9
相关论文
共 35 条
[1]   The epithelial cell cytoskeleton and intracellular trafficking - III. How is villin involved in the actin cytoskeleton dynamics in intestinal cells? [J].
Athman, R ;
Louvard, D ;
Robine, S .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 283 (03) :G496-G502
[2]  
BACCHI CE, 1991, LAB INVEST, V64, P418
[3]   Expression of β-catenin in prostatic adenocarcinomas -: A comparison with colorectal adenocarcinomas [J].
Bismar, TA ;
Humphrey, PA ;
Grignon, DJ ;
Wang, HLL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (04) :557-563
[4]   Mucins and mucin binding proteins in colorectal cancer [J].
Byrd, JC ;
Bresalier, RS .
CANCER AND METASTASIS REVIEWS, 2004, 23 (1-2) :77-99
[5]   Differential expression of α-methylacyl coenzyme A racemase in adenocarcinomas of the small and large intestines [J].
Chen, ZME ;
Ritter, JH ;
Wang, HL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (07) :890-896
[6]   Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine [J].
Chen, ZME ;
Wang, HLL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (10) :1352-1359
[7]   A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990 [J].
Chow, JS ;
Chen, CC ;
Ahsan, H ;
Neugut, AI .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1996, 25 (04) :722-728
[8]   Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease [J].
Corfield, AP ;
Myerscough, N ;
Longman, R ;
Sylvester, P ;
Arul, S ;
Pignatelli, M .
GUT, 2000, 47 (04) :589-594
[9]  
De Lott LB, 2005, ARCH PATHOL LAB MED, V129, P1100
[10]   Pathogenesis and risk factors of small bowel adenocarcinoma: A colorectal cancer sibling? [J].
Delaunoit, T ;
Neczyporenko, F ;
Limburg, PJ ;
Erlichman, C .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03) :703-710